Published in Eur Heart J on November 01, 1996
Factors contributing to episodes of bradycardia hypotension during shoulder arthroscopic surgery in the sitting position after interscalene block. Korean J Anesthesiol (2010) 0.98
Intravenous fentanyl during shoulder arthroscopic surgery in the sitting position after interscalene block increases the incidence of episodes of bradycardia hypotension. Korean J Anesthesiol (2011) 0.90
Swallow syncope after cardiac surgery in a sheep. Vet Surg (2013) 0.85
Hypotensive bradycardic events during shoulder arthroscopic surgery under interscalene brachial plexus blocks. Korean J Anesthesiol (2012) 0.82
Hypotensive and bradycardic episodes in the sitting position during shoulder arthroscopy using interscalene block: can those be alerted? Korean J Anesthesiol (2010) 0.80
P wave dispersion on 12-lead electrocardiography in adolescents with neurocardiogenic syncope. Korean J Pediatr (2016) 0.75
Endogenous opioids, catecholamines and vasovagal syncope. Eur Heart J (1996) 0.75
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. BMJ (2000) 4.21
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. BMJ (2001) 2.85
Seasonal variations in coronary heart disease. QJM (1999) 2.65
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ (1992) 2.64
The potential impact of patient self-referral on mortality in acute myocardial infarction. Q J Med (1993) 2.43
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the 'Utstein Style'. Resuscitation (1993) 2.17
Thrombolysis in myocardial infarction. BMJ (1994) 2.13
Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart (1997) 2.01
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation (2001) 1.78
Management of paroxysmal atrial fibrillation. Q J Med (1993) 1.75
Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction. Eur Heart J (1984) 1.72
Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J (1989) 1.70
Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia. Br Heart J (1992) 1.67
Sex differences in outcome following community-based cardiopulmonary arrest. Eur Heart J (2000) 1.64
Efficacy of out of hospital defibrillation by ambulance technicians using automated external defibrillators. The Heartstart Scotland Project. Resuscitation (1992) 1.60
Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol (1991) 1.59
The time of onset and severity of acidosis in myocardial ischaemia. J Mol Cell Cardiol (1980) 1.50
Acute hepatitis after parenteral amiodarone administration. Br Heart J (1988) 1.46
Congenital and acquired long QT syndrome. Eur Heart J (2000) 1.45
When is it futile for ambulance personnel to initiate cardiopulmonary resuscitation? BMJ (1995) 1.42
Cardiac pacing. Lancet (1997) 1.41
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J (1993) 1.40
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen. J Clin Gastroenterol (1990) 1.40
Cushing's syndrome in a 16 year old girl due to ectopic ACTH precursor production from a pancreatic tumour. Clin Endocrinol (Oxf) (2000) 1.39
Childhood risk factors for ischaemic heart disease and stroke. Paediatr Perinat Epidemiol (1990) 1.35
Acute effects of diuretics on potassium exchange, mechanical function and the action potential in rabbit myocardium. Clin Sci Mol Med Suppl (1978) 1.25
The electrophysiological and mechanical effects of 2,3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart. Exp Physiol (2004) 1.25
QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J (1994) 1.24
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG. Br Heart J (1992) 1.22
Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet (1990) 1.20
Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc Res (2000) 1.19
Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc Res (1992) 1.18
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry (2002) 1.16
Neuroendocrine changes in acute myocardial infarction. Am J Med (1988) 1.16
The causative rhythm in out-of-hospital cardiac arrests witnessed by the emergency medical services in the Heartstart Scotland Project. Resuscitation (1994) 1.11
A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J (1980) 1.11
A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing. Br Heart J (1987) 1.11
Presentation, management, and outcome of out of hospital cardiopulmonary arrest: comparison by underlying aetiology. Heart (2003) 1.11
Ultrafiltration in the management of refractory congestive heart failure. Br Heart J (1986) 1.11
Acute treatment of torsades de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation. Am Heart J (1990) 1.09
Dispersion of ventricular repolarization and refractory period. Cardiovasc Res (2001) 1.09
Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction. Thromb Haemost (1984) 1.08
Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy. Pharmacol Ther (1999) 1.08
Heart rate variability in left ventricular hypertrophy. Br Heart J (1995) 1.07
Haemodynamic effects of prenalterol in patients with coronary heart disease. Br Heart J (1980) 1.07
Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J (1993) 1.06
Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace (2002) 1.05
Percutaneous coronary intervention: obtaining consent and preparing patients for follow-on procedures. Heart (2001) 1.02
Catheter tip pH electrodes for continuous intravascular recording. J Med Eng Technol (1980) 1.02
Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thromb Haemost (2001) 1.01
Response of heart rate to a roller coaster ride. BMJ (1990) 1.01
Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Am J Cardiol (1985) 1.00
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci (2007) 1.00
Surviving out of hospital cardiac arrest at home: a postcode lottery? Emerg Med J (2004) 1.00
Early treatment with captopril after acute myocardial infarction. Br Heart J (1993) 1.00
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension. Gut (1984) 1.00
Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris. Am J Cardiol (1992) 0.99
Myocardial infarction causes increased expression but decreased activity of the myocardial Na+-Ca2+ exchanger in the rabbit. J Physiol (2003) 0.97
Continuous coronary sinus and arterial pH monitoring during pacing-induced ischaemia in coronary artery disease. Br Heart J (1982) 0.96
Chronic memory impairment after cardiac arrest outside hospital. BMJ (1996) 0.94
Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion. Diabetologia (1988) 0.94
Cardiogenic shock and the haemodynamic effects of arrhythmias. Br J Anaesth (1986) 0.93
[Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations]. Ital Heart J Suppl (2002) 0.92
Seasonal variations in out of hospital cardiopulmonary arrest. Heart (1999) 0.92
Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf) (1981) 0.92
Arrhythmogenesis in experimental models of heart failure: the role of increased load. Cardiovasc Res (1996) 0.92
Prolonged asystole induced by head up tilt test. Report of four cases and brief review of the prognostic significance and medical management. Heart (1997) 0.90
Action potential prolongation and potassium currents in left-ventricular myocytes isolated from hypertrophied rabbit hearts. J Mol Cell Cardiol (1998) 0.90
Increase in plasma beta endorphins precedes vasodepressor syncope. Br Heart J (1994) 0.90
Proarrhythmic responses during electrophysiologic testing. Cardiol Clin (1986) 0.89
Lipid peroxidation during myocardial ischaemia induced by pacing. Br Heart J (1990) 0.88
Responses to acute insulin-induced hypoglycaemia in diabetic patients: a comparison of short-acting human and porcine insulins. Diabetes Res (1988) 0.88
Non-uniform prolongation of intracellular Ca2+ transients recorded from the epicardial surface of isolated hearts from rabbits with heart failure. Cardiovasc Res (1998) 0.88
A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial. J Thromb Haemost (2004) 0.88
Congenital complete heart block. Br Med J (Clin Res Ed) (1983) 0.88
Failure of somatostatin analogue SMS 201-995 to control Cushing's syndrome due to ectopic release of ACTH from a bronchial carcinoid. Scott Med J (1989) 0.88
Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group. Am J Cardiol (1995) 0.87
Anatomic variations and abnormalities in the diaphragm seen with US. Radiographics (1990) 0.87
Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1992) 0.86
Tachycardiomyopathy: a diagnosis not to be missed. Heart (2004) 0.86
Effect of sustained stretch on dispersion of ventricular fibrillation intervals in normal rabbit hearts. Cardiovasc Res (1998) 0.86